ADVENTRX logo
Company Products Clinical Trials Partners Investors Resources Contact
Investors

INVESTOR HOME

PRESS RELEASES

PRODUCT DEMONSTRATIONS

EVENTS & WEBCASTS

ANNUAL MEETING

INVESTOR KIT

INFORMATION REQUEST

FAQs

PRESS RELEASES

American Stock Exchange Lists Common Stock Of Adventrx Pharmaceuticals, Inc.

NEW YORK – April 29, 2004 – The American Stock Exchange® (Amex®) today listed the common stock of ADVENTRX Pharmaceuticals, Inc. (Amex: ANX) under the ticker symbol ANX.

ADVENTRX Pharmaceuticals, Inc. is a biopharmaceutical research and development company whose business strategy is to commercialize leading edge medical research through licensing agreements with prominent universities and research institutions. The Company focuses on cancer and antiviral research to launch products that either extend the usefulness of current therapies or replace marginal therapies with new approaches to treatment.

"We are pleased to welcome ADVENTRX Pharmaceuticals to the American Stock Exchange," said John McGonegal, senior vice president of the Amex Equities Group. "The Amex looks forward to working with ADVENTRX in building increased investor awareness and visibility within the investment community."

"This is truly an important milestone for ADVENTRX Pharmaceuticals," said Nicholas Jon Virca, President & CEO of ADVENTRX. "We are moving the Company forward on many fronts and our listing on the AMEX should allow us to become more visible to the investment community as we achieve our initial objectives in cancer and HIV clinical trials during 2004."

The specialist for ADVENTRX Pharmaceuticals will be Cohen Specialists L.L.C. For further information on ANX and other Amex-listed companies, please visit www.amex.com.

The American Stock Exchange® (Amex®) is the only primary exchange that offers trading across a full range of equities, options and exchange traded funds (ETFs), including structured products and HOLDRSSM. In addition to its role as a national equities market, the Amex is the pioneer of the ETF, responsible for bringing the first domestic product to market in 1993. Leading the industry in ETF listings, the Amex lists 138 ETFs. The Amex is also one of the largest options exchanges in the U.S., trading options on broad-based and sector indexes as well as domestic and foreign stocks. For more information, please visit www.amex.com.


COMPANY | PRODUCTS | CLINICAL TRIALS | PARTNERS | INVESTORS | RESOURCES | CONTACT
HOME | CAREERS | SEARCH | SITE MAP | HELP | LEGAL
© Copyright 2008 ADVENTRX Pharmaceuticals

Search Careers Back to homepage